ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      AI Subscribe Login/Register Profile Icon
      S&P 500
      5,614.56
      -2.70%
      US Tech 100
      19,004.00
      0.50%
      Dow Jones
      41,911.71
      -2.08%
      Brent Oil
      69.84
      1.16%
      Bitcoin
      81,787.94
      4.22%
      Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ
      6. Anavex Life Sciences Corporation (AVXL)

      7. Anavex Life Sciences Corporation (AVXL) News

      Anavex Life Sciences Corporation

      Anavex Life Sciences Corporation (AVXL)

      NASDAQ
      8.99
      0.32
      (3.69%)
      Closed March 10 4:00PM
      Delayed by 15 minutes
      8.99
      0.00
      ( 0.00% )
      Pre Market: 5:15AM
      Delayed by 15 minutes

      Your Hub for Real-Time streaming quotes, Ideas and Live Discussions

      Premium

      AVXL News

      Official News Only

      Form 10-Q - Quarterly report [Sections 13 or 15(d)]
      Edgar (US Regulatory)
      February 12 2025
      AVXL (3.69%)

      Form 4 - Statement of changes in beneficial ownership of securities
      Edgar (US Regulatory)
      January 17 2025
      AVXL (3.69%)

      Form 4 - Statement of changes in beneficial ownership of securities
      Edgar (US Regulatory)
      December 23 2024
      AVXL (3.69%)

      Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
      Edgar (US Regulatory)
      December 23 2024
      AVXL (3.69%)

      AVXL Discussion

      View Posts
      Cpap21 Cpap21 43 minutes ago
      News on a partner could be announced any day now.
      The big boys are trying to get in cheap , but our CEO is very confident in his number and will not budge . He told Tom Bishop he was looking out for the shareholders, and he is.
      Look for news very soon !!!’
      Booooom !!!
      👍️0
      georgejjl georgejjl 10 hours ago


      Good luck and GOD bless,
      👍️0
      georgejjl georgejjl 11 hours ago
      9 years and counting

      An Australian TV news interview of Ern Heaven and his wife. Ern had Alzheimer's for over 2 years and was declining when he joined the Anavex phase 2a trial of Anavex 2-73. Over a period of a year on the drug, he first stabilized, and then improved. No other drug has ever helped an Alzheimer's patient improve.

      According to the 1 year trial results, 6 patients out of the initial 32 had "strong" reactions and showed improvements in one or more tests.



      Good luck and GOD bless,
      👍️ 3 👏 1
      mauismart mauismart 11 hours ago
      The golden age of innovation when it comes to finding therapies for alzheimers is not too far away. Just ask the patients who have been on blarcamesine.
      👍️ 7 💯 3 😃 1
      mauismart mauismart 11 hours ago
      I bought a bunch of april 9 dollar calls for.86 today. I think we hold above 9 bucks soon. 10 dollars is not far off either. Go avxl.
      👍️ 5 😃 1
      falconer66a falconer66a 13 hours ago
      Blarcamesine and 3-71 Will Solve U.S. Deficits

      Actually, when blarcamesine, Anavex 3-71, and the other drugs in the Anavex pipeline get approved for all of the anticipated indications, and especially when everyone takes a daily Anavex pill to maintain continuing good health, health care and medical costs will plunge dramatically; so much that our annual federal budget deficits will evaporate. Trillions upon trillions of dollars will be saved.

      [Of course, offered to keep things light; a bit of off-putting sarcasm....]
      🎯 5 👍️ 9 😃 1
      baltimorebullet baltimorebullet 13 hours ago
      This is the only social media platform I'm on.
      Because of Anavex of course.
      And all of you who must share your precious opinions on off topic subjects have managed to ruin this too.
      Do you not have anywhere else to show off your keen insights?
      I'm guessing not.
      Do you not wonder why?
      👍️ 7
      williamssc williamssc 14 hours ago
      Probably so. Like me in retirement I don't make what I did as a working engineer. Retirement income replaced with social security and a pension if your so lucky. I'm one of the luck ones. My wife and I live like my parents did just enjoying life, freezing and canning and going to church. Living frugal. Our carbon foot print is a baby step. lol
      👍️ 8
      falconer66a falconer66a 14 hours ago
      Medicare Costs and Blarcamesine
      And the cheapest solution potentially available, blacarsamine, [to treat Alzheimer's] will benefit if there was belt-tightening.
      As we know, increasing numbers of the elderly are succumbing to Alzheimer's disease each year. They all will need treatment; which in the U.S will involve Medicare or other government funding sources.

      The existing Alzheimer's treatments, the FDA-approved monoclonal antibody drugs, Leqembi, etc., are extremely expensive. Blarcamesine won't be. The cost difference will be a powerful driver for blarcamesine approval and utilization; across the Western world. Government medical insurance agencies save lots and lots of money. Patients do, too. And, blarcamesine is far easier and convenient to take, a single pill a day. No need to be taken to a radiology center to get periodic brain scans to check for brain hemorrhaging or shrinkage. Most importantly, blarcamesine will exhibit far better treatment outcomes.

      Blarcamesine, and Anavex (and its shareholders) will win.
      🎯 4 👍️ 19 💯 2
      kund kund 14 hours ago
      WGT is talking about Medicare and Anavex—it's like putting the cart before the horse. The moron CEO isn’t even talking to the FDA. He first needs to schedule a Type B meeting with the agency and come up with a plan for NDA filing. Even if he starts today, it will take more than a year for an FDA decision. So lay down your pipe and get back to reality.
      👍️ 2 👎️ 1 👺 3
      Bourbon_on_my_cornflakes Bourbon_on_my_cornflakes 14 hours ago
      Correct. Medicare advantage is not government Medicare. People should avoid these plans which look good up front but provide less at their core.

      With "Advantage" plans, the insurer decides if you get treatment. So if you have cancer and are 85, they could say it is not cost-effective to treat you, go die. Kind of like what the original Obamacare was about with Dr. Ezekiel Emmanuel. Death panels doing economics analysis.

      Get supplementary medicare insurance where you and the doctor make the decision on treatment, not an economist.
      👍️ 6
      Hoskuld Hoskuld 14 hours ago
      2-73 should be covered by Medicare part D - and part D premiums are based on income. Do you agree?
      👍️ 1 👎️ 1 👺 1 😁 1
      LakeshoreLeo1953 LakeshoreLeo1953 14 hours ago
      You ARE kidding about Medicare premium pricing?
      Do just a bit of investigating.
      Sight unseen I would take your premium.
      👍️ 1
      Bourbon_on_my_cornflakes Bourbon_on_my_cornflakes 14 hours ago
      Incorrect and silly statement

      Yes, investors here should keep an eye on the political threat to Medicare and Medicaid, since those are critical insurers in the event of FDA approval of blarcamesine and an ultimate source of a great deal of revenue for us in the U.S. Alzheimer's market.

      There is no threat to Medicare, in fact rooting out the fraud and corruption is necessary to protect them. And the cheapest solution potentially available, blacarsamine, will benefit if there was belt-tightening.
      🎯 4 👍️ 5 👎️ 2 👺 1 😃 1 🤣 1
      dia76ca dia76ca 14 hours ago
      AVXL can certainly be a Safe Haven Investment. But it will be affected by the general market. Volumes should be much higher. The share price should already be multiples of the current price!
      However there are powerful catalysts in coming months.
      1. More long term trial (OLE) information.
      2. Anavex 3-71 phase 2b Schizophrenia trial results.
      3. Partnerships for Europe, the UK, Canada and Australia and Asia
      4. European approval for blarcamesine.
      5. FDA discussions leading to priority review.
      There is a worldwide need for blarcamesine and Anavex 3-71. That need will only increase with time.
      Follow the science!
      👍️ 7 😀 1
      williamssc williamssc 14 hours ago
      Medicare premiums are the same for the "less wealthy". Many may not know this but government premiums have risen $30.00 a month for everyone on medicare just to pay the "mab" costs. I'm hoping when Blarcamesine is approved costs will revert back. Hope springs eternal. Praying for a good outcome for medicare folks and everyone else.
      👍️ 7 😀 2
      plexrec plexrec 14 hours ago
      Jonjones--"You never know."--long time no hear from you---good to see you are still around--our day coming soon !!!!
      👍️ 2
      Hoskuld Hoskuld 14 hours ago
      Since you are here on a stock message board, you are probably wealthy. But many are not - and that is when the government and insurance steps in. Undermine that system and the upside lowers.
      👍️ 1 💯 1
      poguemahone poguemahone 15 hours ago
      Cool the engines….one day does not a trend make.
      👍️0
      falconer66a falconer66a 15 hours ago
      AVXL as a Safe Haven Investment?

      Ok, how might a typical, general stock investor perceive things when the stock indices all continue to descend, but the AVXL share price continues to ascend?

      Stock investors do their D.D., due diligence (which is, really, their "determining diligence"). What will potential new AVXL investors find when they search around for the reasons the AVXL share price is rising, contrary to the declining trends of the stock indices?

      Will potential new AVXL buyers see that Anavex science is becoming validated, and large drug sales will begin, especially when the European Medicines Agency approves blarcamesine for Alzheimer's?

      Shortly, will Anavex Life Sciences Corp be a safe haven investment in an otherwise declining equity market? Let's watch.
      👍️ 13 😀 1
      georgejjl georgejjl 15 hours ago
      Expect over 1 million AVXL shares to be bought today!!!

      Good luck and GOD bless,
      👍️0
      boi568 boi568 15 hours ago
      Medicare advantage is not government Medicare. People should avoid these plans which look good up front but provide less at their core. Medicare is run much more leanly than for-profit Medicare advantage plans. However, they all would suffer if Medicare is cut, including any coverage of AD prescriptions.
      👍️ 6
      boi568 boi568 15 hours ago
      Yes, and if the Medicare program isn't funded as well in the future there would be no getting around the shrinking of the AD market in the United States.
      👍️ 1
      rx7171 rx7171 15 hours ago
      Congress created the Advantage option for Medicare at the behest of the insurance industry to get a chance to make profits from Medicare recipients.
      They make profits by minimizing care through procedural run arounds and paperwork.

      I ‘m very happy with my regular Medicare since it is not driven by a profit motive.
      No run around getting coverage when needed.
      🎯 1 👍️ 6
      aredrooster aredrooster 15 hours ago
      Anavex news... like a box of chocolates ... and so on.
      👍️ 2 😃 1
      georgejjl georgejjl 15 hours ago
      How many people expect news regarding Anavex this week???

      Good luck and GOD bless,
      👍️0
      Investor2014 Investor2014 15 hours ago
      Cancer indications - yes!
      👍️0
      williamssc williamssc 15 hours ago
      Medicare advantage has been eroding for years now, they are paying less and less while raising the out of pocket and now most want you to get a referral. Jerking old people around is what they do best. Congress needs to kick these insurers in the keester.
      👍️ 8
      LakeshoreLeo1953 LakeshoreLeo1953 15 hours ago
      “List Price” of Rx for the retired is a fallacy.
      However, $10K/yr premiums and 3-5K deductible is a reality per couple.
      Factor in Dental and Vision…you best be prepared for retirement.

      Of course those able to gamble in pre revenue bio shouldn’t worry…..
      👍️ 1 👎️ 1 👺 1
      Steady_T Steady_T 16 hours ago
      Drugs are covered by Part D plans. Every Medicare recipient chooses which plan they want to enroll in. Each plan has different drugs that it will pay for and those are chosen by the private plans.
      👍️ 1
      williamssc williamssc 16 hours ago
      I like most elderly on medicare pay for our meds. My supplemental prescription plan helps but I still pick up my portion. These plans are not cheap and on top of monthly medicare costs. I don't know anyone getting anything cheap.
      👍️ 8
      Jonjones325 Jonjones325 16 hours ago
      Just doing a little AI searching. Companies can and have been approved after clock stop 1.

      You never know. 
      👍️ 12 😃 2
      Hoskuld Hoskuld 16 hours ago
      If approved, then 2-73 will be a winner.
      👍️ 5
      rx7171 rx7171 16 hours ago
      Here is the published scientific article.
      https://onlinelibrary.wiley.com/doi/10.1111/acel.13037
      👍️ 2
      Steady_T Steady_T 16 hours ago
      Why do you care what I believe? I state my positions on the various Anavex issues. Agree or disagree as you wish. My opinion of the value of other posters is a personal evaluation. I like to keep it that way most of the time. Well, unless there is something so silly I can't help but make fun of it.
      👍️0
      LakeshoreLeo1953 LakeshoreLeo1953 16 hours ago
      The flip side might be…

      Hold 300K shares through $30
      and back to $3 because AVXL
      “has the goods” and WGT. Or one could just take the Sat phone and go fight forest fires.

      Not verifying either scenario, but I think I can figure out which has done better.

      There is always tomorrow, News, and WAGs about performance. This MB does not lack for assurances.
      👍️ 1 👎️ 2 👺 1
      boi568 boi568 16 hours ago
      Yes, investors here should keep an eye on the political threat to Medicare and Medicaid, since those are critical insurers in the event of FDA approval of blarcamesine and an ultimate source of a great deal of revenue for us in the U.S. Alzheimer's market.
      👍️ 2 👎️ 1 🤓 1
      Lacey1 Lacey1 17 hours ago
      The effective and inexpensive will rise to the top in the new environment.
      👍️ 9 😃 2
      Hoskuld Hoskuld 17 hours ago
      Not entirely true because public companies all share the same macro environment. Self-infliected economic distress impacts all companies. But, yes, Anavex does not sell imported steel or aluminum or lumber or oil etc. And maybe the fact that their CEO is German and is fluent in Italian will be a major asset during the MAA process. In the USA, medicare and medicaid pay for a lot of medications - especially for the elderly - so cutting the legs from under those programs could be a problem for drug companies generally and for Anavex specifically.
      👍️ 1 👎️ 2 👺 3 💯 1
      Bourbon_on_my_cornflakes Bourbon_on_my_cornflakes 17 hours ago
      pre-revenue bios unaffected by tariff wars.
      👍️ 2
      Hoskuld Hoskuld 17 hours ago
      Approval is not imminent, nor is it certain (although I think it is probable.) Anavex simply is not subject to all of the same market forces that much of the market is.

      The next value driver will be OLE presentation (April). Then Clock Stop One info (May-June). Then 3-71 top line readout in July. Maybe Anavex gets a partner, too, at some point (wildcard.)
      👍️ 2 👎️ 1 👺 1 😃 2 🧌 1 🧟 1
      georgejjl georgejjl 18 hours ago
      Do you expect NEWS regarding AVXL soon???

      Good luck and GOD bless,
      👍️ 1
      aredrooster aredrooster 18 hours ago
      Perhaps some short covering soon?
      👍️ 5
      powerwalker powerwalker 18 hours ago
      This is not new - from 5½ years ago. I am sure we went through its benefits back then.

      Common Nutrient Supplement May Prevent Alzheimer’s Disease
      By Richard Harth, Arizona State University September 27, 2019 1 Comment8 Mins Read
      👍️ 1
      ohsaycanyousee82 ohsaycanyousee82 18 hours ago
      I assume that you held your 40,000 shares when you had confidence.

      Now you have no confidence and you still hold over half of your shares on what you describe as a lottery ticket.

      That’s a bit of a head scratcher.

      No confidence Doc only holds 1,000 shares just so he can lecture the board as a “shareholder”. I’d adjust my lie down to 1,000 shares just so it appeared to make some sense.
      👍 1
      Investor2014 Investor2014 18 hours ago
      Oh my $AVXL is a $9 stock again - may not be long before my $9.56 purchase begins to make more sense…
      👍️ 1
      falconer66a falconer66a 19 hours ago
      Share Price Counter to the Markets

      Right now I see AVXL trading at $9.15. Up for the day by 5.54%

      But the Dow Jones Industrials are down 1.09%. The NASDAQ is down 3.04%.

      Anavex isn't moving, descending, with the markets. Prospects of imminent European Medicines Agency approval of Blarcamesine for Alzheimer's continues to drive AVXL pricing.

      Then, when the EMA gives formal approval, daily share price increases will be double digit percentages.
      🏆️ 4 👍️ 20 📈 1 😃 2
      Citrati Citrati 19 hours ago
      Wow. 70cent move so far today from bottom to top. Testing that 9.00 area as well.
      Very positive as AVXL is running counter sector and counter market last six trading days.

      https://investorshub.advfn.com/uimage/uploads/2025/3/10/ohldxScreen_Shot_2025-03-10_at_9.45.45_AM.png

      https://investorshub.advfn.com/uimage/uploads/2025/3/10/lporfScreen_Shot_2025-03-10_at_9.48.30_AM.png
      👍️ 8
      ExtremelyBullishZig ExtremelyBullishZig 19 hours ago
      I guess we are unique and you are a sheep. I own over 20,000 share and have owned up to 40,000 8+ years. And yes management here is complete crap. But you follow human nature to a tee...lying to yourself to help you hold on to a crappy investment. I hold on for the "just in case" the slot machine actually shows 3 cherries.
      👍️ 1 👎️ 2 👺 2
      mike_dotcom mike_dotcom 19 hours ago
      UP on a DOWN day in the market? That's almost unheard of. News tomorrow would be nice.
      👍️ 2

      Your Recent History

      NASDAQ
      AVXL
      Anavex Life Sciences
      Delayed Upgrade Clock

      Go Ad-Free

      Subscribe to Ad free and enjoy an ad-free experience

      No Ads

      Try Now

      Keep the Ads